The drug vinpocetine is currently being promoted in Slovakia by certain pharmaceutical company for use in psychiatry. Vinpocetine has a rich history and is mainly used to improve cognitive function after vascular insults/pathology of brain. Does anyone have experience with it in the treatment of cognitive impairment within psychiatry, or in any other indication? Is there any strong clinical reason to resurrect this drug, so to speak? Does it make sense to give it for cognitive symptoms, e.g. in patients with affective disorders? Does it make sense to combine it with ginkgo biloba extract? What are your experiences?

More Michal Patarák's questions See All
Similar questions and discussions